Spire Wealth Management Geron Corp Transaction History

Spire Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$1.19 - $1.65 $29,750 - $41,250	-25,000 Reduced 66.67%	12,500 $19,000
Q1 2022 Apr 18, 2022	SELL	$0.99 - $1.6 $99 - $160	-100 Reduced 0.27%	37,500 $51,000
Q4 2021 Jan 14, 2022	BUY	$1.22 - $1.72 $122 - $172	100 Added 0.27%	37,600 $46,000
Q3 2021 Oct 22, 2021	SELL	$1.2 - $1.5 $24,000 - $30,000	-20,000 Reduced 34.78%	37,500 $51,000
Q2 2021 Jul 26, 2021	SELL	$1.25 - $1.83 $125 - $183	-100 Reduced 0.17%	57,500 $81,000
Q1 2021 May 21, 2021	BUY	$1.52 - $2.1 $87,552 - $120,960	57,600 New	57,600 $91,000

274

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.32B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.